Back to Journals » Breast Cancer: Targets and Therapy » Volume 10

A combination of p53-activating APR-246 and phosphatidylserine-targeting antibody potently inhibits tumor development in hormone-dependent mutant p53-expressing breast cancer xenografts

Total article views   Abstract views HTML views PDF downloads Totals
6,936 Dovepress* 5,541 869+ 1,062 6,410
PubMed Central* 0 526 123 526
Totals 5,541 1,395 1,185 6,936
*Since 22 March 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
38 1 0 0 6 31

View citations on PubMed Central and Google Scholar